Fair Value Calculator Fair Value Calculator
EN DE

CELLA (CELLA) Fair Value & Analysis

IN · Market cap ₹357M

C CELLA CELLA · BSE
Price₹17.71
Fair Value₹23.33
Upside+31.7%
Quality52/100
Watch CELLA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹16.52 – ₹30.14

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +18.0% over the past month.

Price vs Fair Value (12 months)

₹23.60 ₹12.20 Fair Value ₹23.33 Jun 2025 Jul 2026

12‑month range ₹12.20 – ₹23.60 · fair‑value band ₹16.52 – ₹30.14 · the ₹17.71 price screens below the ₹23.33 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CELLA (CELLA) currently trades at ₹17.71, while our model-based Fair Value estimate is ₹23.33 — implying the stock looks roughly 31.7% undervalued today. We read business quality at 52/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, CELLA generated revenue of ₹74.6M at a net margin of 60.8%. Revenue declined 30.8% year over year. It earns a return on equity of 13.8%. Net debt stands at ₹79.0M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹16.52 (bear case) to ₹30.14 (bull case); at ₹17.71, the current price sits within that range. The share trades about 27% below its 52-week high and 48% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹74.6M
Revenue growth (YoY) -30.8%
Net margin 60.8%
Return on equity 13.8%
Free cash flow −₹354M FY2025
P/E ratio 7.9
More key figures
Operating margin 12.0%
EPS (TTM) ₹2.25
EPS growth (YoY) +857%
Net debt ₹79.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

CELLA reported revenue of ₹74.6M in FY2025 versus ₹53.4M in FY2021, a compound +8.7%/yr. Reported net income was ₹45.4M in FY2025, compounding +44.8%/yr from FY2021.

Revenue +8.7%/yr
FY21 ₹53.4M
FY22 ₹74.1M
FY23 ₹77.8M
FY24 ₹24.6M
FY25 ₹74.6M
Net income +44.8%/yr
FY21 ₹10.3M
FY22 ₹11.3M
FY23 ₹2.4M
FY24 ₹514M
FY25 ₹45.4M

Is CELLA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CELLA Fair Value". https://www.fairvalue-calculator.com/stock/CELLA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CELLA (CELLA) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹23.33 versus a price of ₹17.71 — about +32% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CELLA?
Our model-based fair value for CELLA is ₹23.33 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹17.71.
What is the quality score of CELLA?
CELLA has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CELLA (CELLA)?
CELLA reported trailing-twelve-month revenue of about ₹74.6M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CELLA?
The net profit margin of CELLA is about 60.8%, meaning it keeps roughly 60.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.